8-K current report · filed Oct 5, 2026

USANA HEALTH SCIENCES INC (USNA) 8-K Current Report: October 5, 2026

Item 2.03Item 1.01USNA overview

Short answer

USANA HEALTH SCIENCES INC (USNA) filed an 8-K current report with the SEC on October 5, 2026 reporting Item 2.03 (Creation of a Direct Financial Obligation), Item 1.01 (Entry into a Material Definitive Agreement). $75 million revolving credit facility extended to June 27, 2030, with potential increases up to $200 million.

USANA HEALTH SCIENCES INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.03 · Creation of a Direct Financial Obligation

  • $75 million revolving credit facility extended to June 27, 2030, with potential increases up to $200 million
  • New minimum trailing-four-quarter EBITDA covenant: $100 million, reduced to $70 million when lender exposure is $50 million or less
  • General annual asset-sale capacity increased from $500,000 to $2.5 million
  • USANA Australia authorized to sell Sydney real property and deploy net proceeds at management’s discretion
  • Loan parties reaffirmed collateral and representations, with no existing default or event of default disclosed

Other items in this filing:

  • Item 1.01: Entry into a Material Definitive Agreement

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other USANA HEALTH SCIENCES INC 8-K filings

Get the next USNA 8-K as it lands

Follow USNA for push alerts, or ask the research agent what this filing means.